Application 207925
- Type
- NDA
- Sponsor
- VERTEX PHARMS INC
Application Products#
| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|---|---|---|---|---|---|
| 001 | KALYDECO | IVACAFTOR | GRANULE;ORAL | 50MG/PACKET | Yes | No |
| 002 | KALYDECO | IVACAFTOR | GRANULE;ORAL | 75MG/PACKET | Yes | Yes |
| 003 | KALYDECO | IVACAFTOR | GRANULE;ORAL | 25MG/PACKET | Yes | No |
| 004 | KALYDECO | IVACAFTOR | GRANULE;ORAL | 5.8MG/PACKET | Yes | No |
| 005 | KALYDECO | IVACAFTOR | GRANULE;ORAL | 13.4MG/PACKET | Yes | No |
NDC Listings For This Application#
| NDC | Name | Nonproprietary name | Labeler | Marketing category | Status |
|---|---|---|---|---|---|
| 51167-300 | Kalydeco | ivacaftor | Vertex Pharmaceuticals Incorporated | NDA | Current |
| 51167-300 | Kalydeco | ivacaftor | Vertex Pharmaceuticals Incorporated | NDA | Current |
| 51167-300 | Kalydeco | ivacaftor | Vertex Pharmaceuticals Incorporated | NDA | Current |
| 51167-300 | Kalydeco | ivacaftor | Vertex Pharmaceuticals Incorporated | NDA | Current |
| 51167-300 | Kalydeco | ivacaftor | Vertex Pharmaceuticals Incorporated | NDA | Current |
| 51167-400 | Kalydeco | ivacaftor | Vertex Pharmaceuticals Incorporated | NDA | Current |
| 51167-400 | Kalydeco | ivacaftor | Vertex Pharmaceuticals Incorporated | NDA | Current |
| 51167-400 | Kalydeco | ivacaftor | Vertex Pharmaceuticals Incorporated | NDA | Current |
| 51167-400 | Kalydeco | ivacaftor | Vertex Pharmaceuticals Incorporated | NDA | Current |
| 51167-400 | Kalydeco | ivacaftor | Vertex Pharmaceuticals Incorporated | NDA | Current |
| 51167-600 | Kalydeco | ivacaftor | Vertex Pharmaceuticals Incorporated | NDA | Current |
| 51167-600 | Kalydeco | ivacaftor | Vertex Pharmaceuticals Incorporated | NDA | Current |
| 51167-600 | Kalydeco | ivacaftor | Vertex Pharmaceuticals Incorporated | NDA | Current |
| 51167-600 | Kalydeco | ivacaftor | Vertex Pharmaceuticals Incorporated | NDA | Current |
Documents#
| Document | Submission type | Date |
|---|---|---|
| 85473 | SUPPL | 2026-03-24 |
| 85410 | SUPPL | 2026-03-19 |
| 83567 | SUPPL | 2025-09-26 |
| 83539 | SUPPL | 2025-09-26 |
| 82357 | SUPPL | 2025-05-30 |
| 82313 | SUPPL | 2025-05-27 |
| 74993 | SUPPL | 2023-08-04 |
| 74986 | SUPPL | 2023-08-04 |
| 74173 | SUPPL | 2023-05-04 |
| 74169 | SUPPL | 2023-05-04 |
| 65743 | SUPPL | 2020-12-28 |
| 65706 | SUPPL | 2020-12-23 |
| 64687 | SUPPL | 2020-09-25 |
| 64672 | SUPPL | 2020-09-25 |
| 58487 | SUPPL | 2019-04-30 |
| 58481 | SUPPL | 2019-04-30 |
| 55264 | SUPPL | 2018-08-21 |
| 55210 | SUPPL | 2018-08-20 |
| 49207 | SUPPL | 2017-08-02 |
| 49202 | SUPPL | 2017-08-02 |
| 48446 | SUPPL | 2017-05-18 |
| 48441 | SUPPL | 2017-05-18 |
| 47160 | SUPPL | 2017-02-10 |
| 47156 | SUPPL | 2017-02-09 |
| 44964 | ORIG | 2016-04-13 |
| 23041 | ORIG | 2016-04-13 |
| 19973 | ORIG | 2015-04-07 |
| 10626 | ORIG | 2015-03-24 |